Collagen as matrix for neo-organ formation by gene-transfected fibroblasts

Anticancer Research

Volumn 17, Issue 2 A, 1997, Pages 1179-1186

  Rosenthal, Felicia M ^a   Köhler, Gabriele ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Collagen; Fibroblasts; G CSF; Gene therapy; Neo organ

Indexed keywords

COLLAGEN; GRANULOCYTE COLONY STIMULATING FACTOR; PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CULTURE; CELL DEATH; CELL SURVIVAL; COLLAGEN DEGRADATION; CONTROLLED STUDY; FEMALE; FIBROBLAST; GENE EXPRESSION; GENE THERAPY; GENETIC ENGINEERING; GENETIC TRANSFECTION; HEMATOPOIESIS; HISTOLOGY; MOUSE; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL;

EID: 1842406552     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Andersen WF: Prospects for human gene therapy. Science 226: 401-409, 1984.
2. Friedman T: A brief history of gene therapy. Nat Genet 2: 93-98, 1992.
3. Kay MA, Rothenberg S, Landen CN, Bellinger DA, Leland F, Toman C, Finegold M, Thompson AR, Read MS, Brinkhous KM, Woo SLC: In vivo gene therapy of hemophilia B: Sustained partial correction in factor IX-deficient dogs. Science 262: 117-119, 1993.
4. Setoguchi Y, Danel C, Crystal RG: Stimulation of erythropoiesis by in vivo gene therapy: Physiologic consequences of transfer of the human erythropoietin gene to experimental animals using an adenoviros vector. Blood 84: 2946-2943, 1994.
5. Perales JC, Ferkol T, Beegen H, Ratnoff OD, Hanson RW: Gene transfer in vivo: Sustained expression and regulation of genes introduced into the liver by receptor-mediated uptake. Proc Natl Acad Sci USA 91: 4086-4090, 1994.
6. Barr E, Leiden JM: Systemic delivery of recombinant proteins by genetically modified myoblasts. Science 254: 1507-1509, 1991.
7. Roseothal FM, Früh R, Henschler R, Veelken H, Kulmburg P, Mackensen A, Gansbacher B, Mertelsmann R, Lindemann A: Cytokine therapy with gene transfected cells: single injection of irradiated granulocyte-macrophage colony-stimulating factor-transduced cells accelerates hematopoietic recovery after cytotoxic chemotherapy in mice. Blood 84: 2960-2965, 1994.
8. Louis DSt, Verma IM: An alternative approach to somatic cell gene Proc Natl Acad Sci USA 85: 3150-315, 1988.
9. Selden RF, Skosjiewicz MJ, Howie KB, Russell PS, Goodman HW: Implantation of genetically engineered fibroblasts into mice: Implications for gene therapy. Science 236: 714-718, 1987.
10. Moullier P, Marechal V, Danos O, Heard JM: Continuous systemic-secretion of a lysosomal enzyme by genetically-modified mouse skin fibroblasts. Transplantation 56: 427-432, 1993.
11. Veelken H, Jesuiter H, Mackensen A, Kulmburg P, Schultze J. Rosenthal FM, Mertelsmann R, Lindemann A: Primary fibroblasts from human adults as target cells for ex vivo transfection and gene therapy. Hum Gene Ther 5: 1203-1209, 1994.
12. Rosenthal FM, Kulmburg P, Früh R, Pfeifer C, Köhler G, Veelken H, Mackensen A, Lindemann A, Mertelsmann R: Systemic hematological effects of granulocyte colony-simulating factor produced by irradiated gene-transfected tumor cells and fibroblasts. Hum Gene Ther 7: 2147-2156, 1996.
13. Palmer TD, Rosman GJ, Osborne WR, Miller AD: Genetically modified skin fibroblasts persist long after transplantation but gradually inactivate introduced genes. Proc Natl Acad Sci USA 88: 1330-1334, 1991.
14. Scharfmann R, Axelrod JH, Verma IM: Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants. Proc Natl Acad Sci USA 88: 4626-4630, 1991.
15. Ramesh N, Lau S, Palmer TD, Storb R. Osborne WRA: High-level human adenosine deaminase expression in dog skin fibroblasts is not sustained following transplantation. Hum Gene Ther 4: 3-7, 1993.
16. Dichet DA, Bratthauer GL, Beq ZH, Anderson KD, Newman KD, Zwiebel JA, Hoeg JM, Anderson WF: Retroviral vector-mediated in vivo expression of low-density-lipoprotein receptors in the Watanabe heritable hyperlipidemic rabbit. Som Cell Mol Gen 17: 287-301, 1991.
17. Moullier P, Bohl D, Heard JM, Danos O: Correction of lysosomal storage in the liver and spleen of MPS VII mice by implantation of genetically modified skin fibroblasts. Nat Genet 4: 154-159, 1993.
18. Mouiller P, Bohl D, Cardoso J, Heard J-M, Danos O: Long-term delivery of a lysosomal enzyme by genetically modified fibroblasts in dogs. Nat Med 7: 353-357, 1995.
19. Gilbert JC, Takada T, Stein JE, Langer R, Vacanti JP: Cell transplantation of genetically altered cells on biodegradable polymer scaffolds in syngeneic rats. Transplantation 56: 423-427, 1993.
20. Dwarki VJ, Belloni P, Nijjar T, Smith J, Couto L, Rabier M, Clift S, Berns A, Cohen LK: Gene therapy for hemophilia A: production of therapeutic levels of human factor VIII in vivo in mice. Proc Natl Acad Sci USA 92: 1023-1027, 1995.
21. Brandt SJ, Peters WP, Atwater SK, Kurtzberg J, Borowilz MJ, Jones RB, Shpall EJ, Bast RC. Gilbert CJ, Oette DH: Effect of recombinant human granulocyte colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation. N Engl J Med 319: 869-876, 1988.
22. Gomori G: Silver impregnation of reticulum in paraffin sections. Am J Pathol 13: 993-1002, 1937.
23. Heartlein MW, Roman VA, Jiang J-L, Sellers JW, Zuliani AM, Treco DA, Selden R: Long-term production and delivery of human growth hormone in vivo. Proc Natl Acad Sci USA 91: 10967-10971, 1994.
24. Tripathy SK, Black HB, Goldwasser E, Leiden JM: Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nat Med 2: 545-550, 1996.
25. Palmer TD, Thompson AR, Miller AD: Production of human factor IX in animals by genetically modified skin fibroblasts: potential therapy for hemophilia B. Blood 73: 438-445, 1989.
26. Liu H-W, Ofosu FA, Chang PL: Expression of human factor IX by microencapsulated recombinant fibroblasts. Hum Gene Ther 4: 291-301, 1993.
27. Al-Hendy A, Hortelano G, Tannenbaum GS, Chang PL: Correction of the growth defect in dwarf mice with nonautologous microencapsulated myoblasts - an alternative approach to somatic gene therapy. Hum Gene Ther 6: 165-175, 1996.
28. Tani K, Ozawa K, Ogura H, Takahashi T, Ohano A, Watari K, Matsudaira T, Tajika K, Karasuynma H, Nagata S, Asano S, Takaku F: Implantation of fibroblasts transfected with human granulocyte colony-stimulating factor cDNA into mice as a model of cytokine supplement gene therapy. Blood 74: 1274-1280, 1989.
29. Brauker J, Carr-Brendel S, Neunenfeldt S, Clarke D, Hodgett D, Vergolh C, Stone W, Dwarki V, Chen R, Nijjar T, Loudovaris T. Martinson L, Young S, Jacobs S, Geller R, Maryanov D, Levon S. Johnston W, Johnson RC: Immunoisolation in somatic cell gene therapy [abstract]. J Cell Biochem 21B: D1-015, 1995.
30. Aebischer P, Schluep M, Deglon N, Joseph JM, Hirt L, Heyd B, Goddard M, Hammang JP. Zurn AD, Kalo AC, Regli F, Buetge EE: Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis. Nat Med 2: 696-699, 1996.
31. Kuzuya M, Kinsell JL: Induction of endothelial cell differentiation in vitro by fibroblast-derived solube factors. Exp Cell Res 215: 310-318, 1994.